Aim-To review the presenting clinical features and the histology of cases of non-
histochemically for CD45, CD3, CD45RO, CD20, and CD30. Sections were stained with either naphthol AS-D chloroacetate esterase or KP1 (CD68) to identify granulocytic tumours. In a minority of cases, additional immunohistochemical stains were performed when necessary to establish the diagnosis. The sections were reviewed by three pathologists. Results-Of 308 cases analysed, 293 were categorised as NHL. There was only one case of low grade lymphoma in the series. Over 80% of the cases fell into the categories Burkitt lymphoma (42.2%), lymphoblastic lymphoma (27.2%) and anaplastic large cell lymphoma (15.1%). Cases of Burkitt lymphoma presented most often with abdominal tumours mainly of the ileocaecal region. Tumours of the oropharynx and nasopharynx were also common in this group. Of the 84 lymphoblastic lymphomas, 56 were of the T-cell phenotype, 12 of the B-cell phenotype and 16 of indeterminate lineage. Most of the T-lymphoblastic lymphomas showed mediastinal or pleural involvement. Infiltration of the skin and soft tissues was seen in 25% of lymphoblastic lymphoma of B or indeterminate phenotype. Forty six children were diagnosed as having anaplastic large cell lymphoma, the majority being of T or indeterminate lineage. Most patients presented with lymphadenopathy but involvement ofthe bones, soft tissues or skin was seen in seven patients and of the mediastinum and lungs in five. Conclusion-Childhood non-Hodgkin lymphomas are almost all high grade and frequently extranodal. They fall mainly into the categories Burkitt lymphoma, lymphoblastic lymphoma and anaplastic large cell lymphoma. The separation of these subcategories can be made on Non-Hodgkin lymphomas represent 4-6% of all malignant neoplastic disease of childhood.' About 85% of children in the United Kingdom with non-Hodgkin lymphomas are enrolled in the NHL trials organised by the United Kingdom Children's Cancer Study Group (UK-CCSG), amounting to approximately 80 new cases each year. The original diagnostic biopsy specimens from these children were examined by a separate review panel and, in this report, the panel's findings are presented for nearly 300 cases. Paediatric non-Hodgkin lymphomas differ from the adult disease, in that they are almost all high grade, have a diffuse growth pattern and commonly involve extranodal sites. The majority of our cases fell into one of three diagnostic groups: Burkitt lymphoma, lymphoblastic lymphoma and anaplastic large cell lymphoma. Treatment regimes for these three categories differ,' and as they are rapidly progressive tumours, optimum management requires both prompt and accurate histological diagnosis.
Methods
Ten unstained paraffin wax sections and a copy of the pathology report were requested for all patients entered into the UKCCSG NHL trials. In exceptional cases, a tissue block was submitted and occasionally the panel chairman obtained additional sections. Many of the biopsy specimens had already been referred to a paediatric pathologist at the treatment centre for review and the results of the investigations done at the referral laboratory were usually available. All sections were stained with haematoxylin and eosin and with Giemsa stain. Immunohistochemistry, using either the APAAP or the immunoperoxidase method, was performed routinely with CD45, the lineage markers CD3 and CD20, and with CD45RO (UCHL1) and CD30. In the early part of the study, one section was routinely stained for naphthol AS-D chloroacetate esterase to identify granulocytic tumours. This was later replaced by immunohistochemical staining for CD68 (KP1). Sections in individual cases were also stained with antibodies directed against Childhood non-Hodgkin lymphomas in the United Kingdom BURNTT LYMPHOMAS Burkitt lymphomas showed a monomorphic proliferation of blast cells with rounded nuclei and granular nuclear chromatin. The cells contained one to four nucleoli which were identifiable but rarely prominent. Tumours always showed a high mitotic index and large numbers of apoptotic cells and nuclear fragments. The latter were often engulfed by macrophages that gave the tumour a characteristic starry sky appearance (fig 1) . Burkitt lymphoma cells had a well-defined, but narrow, rim of deeply basophilic cytoplasm, best seen in Giemsa stained sections and usually best visualised at the edge of the section (fig 2) . Small vacuoles corresponding to lipid droplets were seen within this rim of cytoplasm in many cases ( fig 2) . The tumour cells were positive for CD45 and CD20 and negative for T-lineage markers and CD30.
LYMPHOBLASTIC LYMPHOMAS
Lymphoblastic lymphomas also showed a monomorphic proliferation of blast cells with round, oval or convoluted nuclear outlines. The nuclear chromatin was fine and dispersed with two to four small nucleoli. Tumours showed a high mitotic index with frequent apoptotic cells. A starry sky pattern with vacuolated macrophages was occasionally seen but was rarely as prominent as in Burkitt lymphoma (fig 3) . The cytoplasm of these cells was inconspicuous and showed weak to moderate basophilia in the Giemsa stain in contrast to Burkitt lymphoma cells (fig 4) . Most lymphoblastic lymphomas were positive for CD45 but 13 examples did not stain; nine CD3, and B-lineage tumours by the expression of CD20. Tumours expressing neither CD3 nor CD20 were categorised as being of indeterminate lineage. expressed. Staining for terminal deoxynucleotidyl transferase, which has recently been reported in paraffin wax embedded tissue sections,4 would also provide a marker for precursor B-or T-cell lymphomas (lymphoblastic lymphomas). The only major area of disagreement between the panel diagnosis and that of the referring pathologists was of Burkitt lymphoma which was originally described as B-lymphoblastic lymphoma in 35 cases. This discordance, however, relates more to the use of terminology than to histological interpretation. Burkitt lymphoma was categorised as a B-lymphoblastic lymphoma in the first version of the Kiel classification,5 an error that was subsequently rectified in the updated version of this classification.6 In the FAB classification of lymphoblastic leukaemia, cases of Burkitt lymphoma with extensive bone marrow involvement and overspill into the peripheral blood are still referred to as acute lymphoblastic lymphoma (ALL-L3).7 Lymphoblastic lymphomas arise from early or progenitor B and T cells, whereas Burkitt lymphoma cells show features of more mature B cells in their expression of lineage markers and surface immunoglobulin. The molecular genetics of Burkitt lymphoma and B-lymphoblastic lymphoma are different, as are their immunophenotype and morphology.8 There is a need for classification systems to make a clear distinction between these separate diseases.
Burkitt lymphoma is the commonest subtype of childhood non-Hodgkin lymphoma in the UK. By definition, this is categorised as sporadic or non-endemic Burkitt lymphoma. Endemic and non-endemic Burkitt lymphoma are morphologically indistinguishable,9 probably because both groups of tumours have translocations between the c-myc gene and one of the immunoglobulin genes, leading to c-myc deregulation.'0 Deregulated c-myc results in cells that continuously replicate but do not differentiate and, therefore, show little morphological variation. Despite their morphological identity, endemic and sporadic Burkitt lymphoma differ in their molecular genetics, in that the breakpoints in relation to the c-myc and immunoglobulin genes are usually different." [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In addition, endemic Burkitt lymphoma is always associated with EpsteinBarr virus, whereas only one third of nonendemic cases carry the virus. '4 The two tumours also differ in their clinico-anatomical features. Endemic Burkitt lymphoma has a sex ratio of 2.1 males to one female, '5 whereas in this series the ratio was 5.5:1. Non-endemic Burkitt lymphoma presents most frequently with abdominal and pelvic tumours, often involving the ileocaecal region. The oropharynx and nasopharynx are the second most common tumour sites. This anatomical distribution would be uncommon in endemic Burkitt lymphoma in which abdominal tumours are usually retroperitoneal and tumours of Waldeyer's ring are rare.'6 Peripheral lymphadenopathy is almost never seen in endemic Burkitt lymphoma, whereas it was a presenting feature in 10% of the cases of non-endemic Burkitt lymphoma in this series.
The clinical and anatomical differences between endemic and sporadic Burkitt lymphoma have been recorded previously."7 If
Burkitt lymphoma had not been defined on the basis of its microscopic features which, as stated above, are probably directly related to c-myc deregulation, the sporadic disease would not have been labelled as Burkitt lymphoma. The semantic confusion surrounding these tumours has been further complicated by the use of the terms "Burkitt-like" or "small non-cleaved cell non-Burkitt". When applied to childhood lymphomas, the distinction between Burkitt 
